ACTIVE

UNIVERSAL PHARMA

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result2 M €+9,7 %over 1 year

Revenue51,5 M €+5,9 %over 1 year

Equity23,1 M €+8,4 %over 1 year

Workforce134,5 ETP-0,8 %over 1 year

Identity

Source · BCE/KBO

UNIVERSAL PHARMA is a Public limited company incorporated in 1992. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Frameries. It employs on average 134,5 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0447.382.113
Incorporation: 12/05/1992
Legal form: Public limited company
Registered office: Rue Montavaux 155
7080 Frameries · WallonieSee on map
Contributed capital: 1 500 000,00 €
Latest accounts: 31/12/2025
Average workforce: 134,5 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation 52310Warehousing and support activities for transportation

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

Financials

Source · NBB, 21 filings

Trend over 20 financial years

	2025		2024		2023		2022		2021
Income statement
Revenue	51,5 M €	+5.9%	48,7 M €	+16.7%	41,7 M €	+5.0%	39,7 M €	+6.5%	37,3 M €
EBITDA	3,1 M €	+13.5%	2,7 M €	+33.4%	2 M €	-19.5%	2,5 M €	-14.9%	3 M €
Operating result	2,3 M €	+12.4%	2 M €	+42.9%	1,4 M €	-30.9%	2,1 M €	-17.0%	2,5 M €
Net result	2 M €	+9.7%	1,9 M €	+33.0%	1,4 M €	-27.4%	1,9 M €	-13.3%	2,2 M €
Balance sheet
Equity	23,1 M €	+8.4%	21,3 M €	+5.5%	20,2 M €	+2.0%	19,8 M €	+10.8%	17,8 M €
Total assets	31,5 M €	+8.8%	29 M €	+0.0%	29 M €	+8.7%	26,6 M €	+12.5%	23,7 M €
Cash	5,2 M €	+28.3%	4 M €	-12.7%	4,6 M €	+41.7%	3,3 M €	+69.2%	1,9 M €
Debts	8,2 M €	+12.2%	7,3 M €	-13.0%	8,4 M €	+23.7%	6,8 M €	+22.1%	5,6 M €
Other
Workforce	134,5 ETP	-0.8%	135,6 ETP	+2.6%	132,1 ETP	+9.2%	121,0 ETP	+4.3%	116,0 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 10 M€ and 25 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 3 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
FINPHARMA SA LU23789688Represented by PHILIPPE BOULANGER	Director05/10/2020 → 30/06/2030
GESTIPHARMA0425.530.684Represented by PIERRE-PASCAL HECQ	Managing director02/06/2016 → 30/06/2030

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
FARMIMMO0429.198.175Represented by PIERRE-PASCAL HECQ	Director05/10/2020 → 2023 accounts
ASSCOT0447.778.625	Director02/06/2016 → 2020 accounts

Other companies at this address

Rue Montavaux 155 7080 Frameries

Company	CBE no.
ASSCOT● Active	0447.778.625
ATRIUM MANAGEMENT● Active	0478.169.913
BEPHAR● Active	0450.260.538
EVRAS● Active	0417.723.174
FARMIMMO● Active	0429.198.175
FELIX PHARMA● Active	0477.939.091
IMMOBILIERE DES QUATRE SEIGNEURIES● Active	0443.155.782
Immobilière Général Léman● Active	0403.358.761
IMMOBILIERE PRIMA● Active	0466.956.812
IMMOBILIERE SAINT GEORGES● Active	0435.700.442
Les Pharmacies Réunies● Active	0403.082.213
OBIPHAR● Active	0878.100.418
PHARMACIE ANDROMEDE● Active	0882.318.631
PHARMACIE CLAERHOUT● Active	0423.162.203
Pharmacie de la Chasse Royale● Active	0867.368.654
PHARMACIE DE LA PLACE DE GHLIN● Active	0842.900.009
PHARMACIE FAIDHERBE● Active	0479.179.208
Pharmacie Grenez - Seeuws● Active	0419.745.130
PHARMACIE RONDEAU● Active	0447.088.737
PHARMACIE SCHNEIDER - DEPOUHON● Active	0439.400.397

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	07/07/2026	03/07/2025	28/08/2024	26/07/2023	18/08/2022	17/08/2021
General meeting	30/06/2026	30/06/2025	30/06/2024	28/06/2023	30/06/2022	30/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 21 filings

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	30/06/2026	07/07/2026	French	PDF
Full model	31/12/2024	30/06/2025	03/07/2025	French	PDF
Full model	31/12/2023	30/06/2024	28/08/2024	French	PDF
Full model	31/12/2022	28/06/2023	26/07/2023	French	PDF
Full model	31/12/2021	30/06/2022	18/08/2022	French	PDF
Full modelCorrection	31/12/2020	30/06/2021	17/08/2021	French	PDF
Full model	31/12/2020	30/06/2021	09/08/2021	French	PDF
Full model	31/12/2019	26/06/2020	12/08/2020	French	PDF
Full model	31/12/2018	30/06/2019	08/08/2019	French	PDF
Full model	31/12/2017	08/06/2018	02/08/2018	French	PDF
Full model	31/12/2016	30/06/2017	17/07/2017	French	PDF
Full model	31/12/2015	30/06/2016	26/07/2016	French	PDF
Full model	31/12/2014	30/06/2015	29/07/2015	French	PDF
Full model	31/12/2013	30/06/2014	28/07/2014	French	PDF
Full model	31/12/2012	30/06/2013	12/07/2013	French	PDF
Full model	31/12/2011	30/06/2012	09/07/2012	French	PDF
Full model	31/12/2010	30/06/2011	29/07/2011	French	PDF
Full model	31/12/2009	30/06/2010	26/08/2010	French	PDF
Full model	31/12/2008	25/06/2009	05/08/2009	French	PDF
Full model	31/12/2007	13/06/2008	22/08/2008	French	PDF
Full model	31/12/2006	08/06/2007	02/08/2007	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 10 M€ and 25 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 3 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
FINPHARMA SA LU23789688Represented by PHILIPPE BOULANGER	Director05/10/2020 → 30/06/2030
GESTIPHARMA0425.530.684Represented by PIERRE-PASCAL HECQ	Managing director02/06/2016 → 30/06/2030

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
FARMIMMO0429.198.175Represented by PIERRE-PASCAL HECQ	Director05/10/2020 → 2023 accounts
ASSCOT0447.778.625	Director02/06/2016 → 2020 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates13/10/2026
Reconduction mandat du Commissaire-Réviseur
PDF
Mandates04/12/2024
DEMISSIONS, NOMINATIONS
PDF
Mandates29/12/2023
DEMISSIONS, NOMINATIONS
PDF
Other20/10/2022
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates22/12/2021
DEMISSIONS, NOMINATIONS - DIVERS
PDF
Mandates06/11/2020
DEMISSIONS, NOMINATIONS
PDF
Mandates03/08/2016
DEMISSIONS, NOMINATIONS
PDF
Other27/12/2013
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings20 filings

Mandates

GESTIPHARMA

FINPHARMA SA LU23789688

FARMIMMO

ASSCOT

PIERRE PASCAL HECQ

199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027202820292030

UNIVERSAL PHARMA

Rue Montavaux 155, 7080 Frameries

Managing director

Director

Managing director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Rue Montavaux 155, 7080 FrameriesCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00269972

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
UNIVERSAL PHARMACurrent	accounts 2006 → 2025	Accounts 2025 · 2026-00269972

Events

2025
Annual accounts 20252 M €↑
2024
Annual accounts 20241,9 M €↑
2023
Annual accounts 20231,4 M €↓
2022
Annual accounts 20221,9 M €↓
2021
Annual accounts 20212,2 M €↑
2020
Annual accounts 20202,2 M €↑
2019
Annual accounts 2019970,3 k €↓
2018
Annual accounts 20181,2 M €↑
2017
Annual accounts 20171 M €↓
2016
Annual accounts 20161,2 M €↑
2015
Annual accounts 20151,1 M €↑
2014
Annual accounts 2014854,7 k €↑
2013
Annual accounts 2013691 k €↑
2012
Annual accounts 2012122,7 k €↓
2011
Annual accounts 2011506,6 k €↑
2010
Annual accounts 2010415,4 k €↑
2009
Annual accounts 2009309 k €↑
2008
Annual accounts 2008271,3 k €↓
2007
Annual accounts 2007487,5 k €↓
2006
Annual accounts 2006583,9 k €
12/05/1992
IncorporationPublic limited company

UNIVERSAL PHARMA

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events